Benzinga··Vandana SinghAbivax Dismisses M&A Speculation, Plans Capital Raise Before Trial Readout
Abivax CEO dismisses acquisition rumors, plans equity and debt raise after Phase 3 obefazimod data in Q2 2026. $614.42M cash runway supports strategy.
LLYAZNABVXFDA approvalbiotech